financetom
Business
financetom
/
Business
/
US senators unveil bill to prevent export monopolies after Huawei showdown 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US senators unveil bill to prevent export monopolies after Huawei showdown 
Nov 19, 2025 2:47 PM

WASHINGTON (Reuters) -A bipartisan duo of U.S. senators unveiled a bill on Wednesday that directs the Commerce Department to create a level playing field when issuing export licenses and not make decisions that benefit one U.S. company over another. 

The legislation, drafted by Democrat Elizabeth Warren and Republican Rick Scott, comes after the Commerce Department drew fire for granting licenses to Intel and Qualcomm to sell chips to Huawei without approving similar sales to the heavily sanctioned Chinese telecom giant by rivals MediaTek and AMD. 

The Biden administration eventually revoked Intel and Qualcomm's licenses last year, but concerns have festered about the Commerce Department's ability to create an unfair playing field among U.S. competitors vying to maintain access to overseas customers whose purchases of American technology require licenses for national security reasons. 

"Monopoly licenses have the potential to create serious distortion in the market, exacerbate economic and security vulnerabilities, and undermine fairness in the export licensing regime," according to the text of the bill, which has not been previously reported. 

If approved, the legislation would require the agency, which oversees U.S. export control policy, to conduct a "competitive market review" when considering a license request to determine if the exporter would become the only firm authorized to ship that item to a potential buyer. Such a license would only then receive approval if no similar license has been sought by rivals for the same customer.  

The Commerce Department did not immediately respond to a request for comment. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aclaris Therapeutics Q3 revenue beats estimates, net loss narrows
Aclaris Therapeutics Q3 revenue beats estimates, net loss narrows
Nov 6, 2025
Overview * Aclaris Q3 revenue beats analyst expectations despite a year-over-year decline * Net loss for Q3 smaller than expected, reflecting better financial performance * Company reports positive Phase 2a trial results for ATI-2138 in atopic dermatitis Outlook * Aclaris plans Phase 2 trial of ATI-2138 in H1 2026 for new indications * Company expects Phase 1b trials of ATI-052...
ConocoPhillips Q3 profit beats on increased production volumes
ConocoPhillips Q3 profit beats on increased production volumes
Nov 6, 2025
Overview * ConocoPhillips ( COP ) Q3 adjusted EPS of $1.61 beats analyst expectations * ConocoPhillips ( COP ) raises quarterly dividend by 8% to $0.84 per share Outlook * ConocoPhillips ( COP ) expects 2026 capital expenditures of $12 bln * Company forecasts 2026 adjusted operating costs at $10.2 bln * ConocoPhillips ( COP ) anticipates 0 to 2%...
Advanced Drainage Systems Fiscal Q2 Adjusted Earnings, Revenue Rise; Raises Fiscal 2026 Revenue Guidance
Advanced Drainage Systems Fiscal Q2 Adjusted Earnings, Revenue Rise; Raises Fiscal 2026 Revenue Guidance
Nov 6, 2025
07:08 AM EST, 11/06/2025 (MT Newswires) -- Advanced Drainage Systems ( WMS ) reported fiscal Q2 adjusted earnings Thursday of $1.97 per diluted share, up from $1.70 a year earlier. Analysts surveyed by FactSet expected $1.64. Revenue for the quarter ended Sept. 30 was $850.4 million, compared with $782.6 million a year earlier. Analysts surveyed by FactSet expected $801 million....
ProQR Q3 revenue misses estimates, reports net loss
ProQR Q3 revenue misses estimates, reports net loss
Nov 6, 2025
Overview * ProQR Q3 revenue missed analyst expectations * Company reported a net loss of €11 mln for Q3 2025 * ProQR received CTA authorization for Phase 1 trial of AX-0810 Outlook * ProQR expects initial safety data for AX-0810 by end of 2025 * Target engagement data for AX-0810 expected in H1 2026 Result Drivers * CASH POSITION -...
Copyright 2023-2026 - www.financetom.com All Rights Reserved